Biomedical Engineering / Pacemaker Strength-Duration
FREE TO EXPLORE
LABORATORY 39 · BIOMEDICAL ENGINEERING

Pacemaker Strength-Duration theory

Understand pacemaker strength-duration: governing biomedical equations, biopotentials, constitutive tissue models, and medical devices.

Biomedical and physiological foundations of Pacemaker Strength-Duration.

Implantable cardiac pacemakers are life-sustaining electronic medical devices that treat symptomatic bradyarrhythmias, high-grade atrioventricular (AV) blocks, and sick sinus syndrome by delivering timed electrical stimulation pulses to myocardial tissue. The electrical excitability of excitable cardiac cell membranes is governed by the classic neurostimulation principles formulated by Louis Lapicque and Georges Weiss. To trigger an action potential that propagates across the myocardium and initiates coordinated ventricular contraction ('capture'), the delivered electrical pulse must depolarize the cell membrane from its resting potential (-85 mV) to its threshold potential (-65 mV). The minimum stimulation voltage V_th required for capture depends on pulse duration t_p according to the Lapicque strength-duration relationship: V_th = V_rh · (1 + t_ch / t_p) = (V_rh · t_ch) · (1 / t_p) + V_rh = m_ch · (1 / t_p) + V_rh, where V_rh is the rheobase voltage (the asymptotic minimum voltage threshold at infinitely long pulse width), t_ch is the chronaxie time (the pulse duration required to achieve capture at exactly twice the rheobase voltage: V_th = 2 · V_rh), and m_ch = V_rh · t_ch is the Lapicque slope constant (V·ms). In clinical pacemaker programming, setting pulse width near the chronaxie (typically 0.4 to 0.5 ms for modern steroid-eluting steroid collar leads) optimizes battery longevity by minimizing delivered pacing energy (E = V² · t_p / R). In this experiment, an instrumented cardiac electrophysiology simulator evaluates pacemaker threshold voltages across pulse durations from 0.2 to 1.0 ms.

V_th = m_ch · (1/t_p) + V_rh = 0.3200 · (1/t_p) + 0.6500

Viva voce questions & analytical theory

What is the physical definition of rheobase voltage and chronaxie time?

Rheobase is the absolute minimum electrical potential required to elicit an action potential at infinitely long pulse duration; chronaxie is the specific pulse duration at which the threshold voltage is exactly twice the rheobase voltage (V_th = 2 · V_rh).

Why is the chronaxie pulse width considered the energy-optimal setting for pacemaker programming?

Delivered pacing energy is E = V²·t_p / R. At very short pulse widths, required voltage rises sharply, causing high V² energy loss; at very long pulse widths, extra duration wastes energy after the cell has already depolarized. Mathematical optimization proves that delivered pacing energy reaches a minimum near t_p ≈ chronaxie (typically 0.4 to 0.5 ms).

How do steroid-eluting pacing leads lower chronic pacing thresholds?

Mechanical insertion of a lead causes local foreign-body trauma, acute inflammation, and fibrous capsule formation around the electrode tip. A slow-eluting steroid (dexamethasone) suppresses local inflammation and minimizes fibrous scar tissue thickness, reducing the effective pacing radius and lowering chronic capture thresholds by > 50%.

What is the difference between unipolar and bipolar pacing configurations?

In unipolar pacing, the cathode is the lead tip in contact with myocardium and the anode is the metallic pacemaker casing (can), creating large pacing spikes on surface ECG but risking pectoral muscle twitching; in bipolar pacing, both cathode (tip) and anode (ring) are on the lead tip inside the heart, eliminating pectoral stimulation and reducing electromagnetic interference (EMI).

What is automated capture management (AutoCapture) in modern pacemakers?

AutoCapture delivers a pacing pulse, listens for an evoked myocardial response (depolarization wave) within a 50 ms window, delivers a high-voltage safety backup pulse if capture is lost, and periodically recalibrates the threshold, maintaining a safe 0.3 V safety margin to dramatically extend battery life.

What is pacemaker lead maturation and how does threshold change over time?

Immediately post-implant, thresholds are low (~0.5 V); over 1 to 3 weeks, acute inflammation causes thresholds to rise to a peak (peaking phase); after 6 to 12 weeks, steroid elution resolves inflammation, stabilizing the chronic threshold at a low, permanent baseline.

Experimental precautions and patient safety

  • Always maintain a clinical safety margin (typically programming output voltage to at least 2 times capture threshold or 3 times safety margin) to prevent loss of capture.
  • Ensure pacemaker lead tip is fully submerged in physiological saline to prevent electrode polarization artifacts.
  • Verify oscilloscope input impedance is > 1 MΩ to avoid loading the pacemaker output circuit.
  • Allow 10 pacing cycles at each voltage step during threshold testing to ensure 100% reliable myocardial capture.

Theoretical assumptions & biological limits

  • The Lapicque-Weiss model assumes a simple parallel R-C membrane circuit, neglecting active voltage-gated sodium channel reactivation dynamics.
  • In-vitro saline testing uses a fixed resistor-capacitor network; living human myocardium exhibits time-varying non-linear polarization impedances.
  • Evaluates acute thresholds; does not model chronic fibrous capsule remodeling or post-operative threshold maturation.
  • Does not simulate autonomic tone variations (exercise, circadian catecholamine surges) that alter in-vivo myocardial excitability.
↳
Connect physiological theory to empirical clinical data.

Evaluated on a Medtronic clinical cardiac pulse generator interfaced with a steroid-eluting active-fixation bipolar endocardial pacing lead (tip area 1.2 mm², pacing impedance R = 550 Ω) immersed in 37.0 °C physiological saline. Rheobase voltage V_rh = 0.6500 V, chronaxie time t_ch = 0.4923 ms, yielding Lapicque slope m_ch = 0.3200 V·ms across pulse widths t_p from 0.20 to 1.00 ms (1/t_p from 5.0 to 1.0 ms⁻¹).